44th Annual William K. Ishmael Lectureship


Date & Location
Friday, September 7, 2018 7:30 AM - 2:45 PM   OMRF Wileman Audtiorium, 825 NE 13th Street, Oklahoma City, OK

Target Audience
Family Medicine, General Medicine, Pediatrics, Primary Care Physicians, Rheumatology

Overview
The 44th Annual William K. Ishmael Lectureship is an educational lectureship aimed at disseminating the latest in basic and clinical rheumatologic research to rheumatologists from the Oklahoma City region.  The meeting is organized as a one-day event, held at the Oklahoma Medical Research Foundation, consisting of lectures, networking, exhibitors and a ‘meet the professor’ session, where attendees are encouraged to discuss, in small group format, interesting cases from their own past experience with our guest experts.   
This year, we have distinguished national speakers including Leanne Ginsler, MD, of the Unviersity of California San Francisco Medical Center, who will discuss psoriatic arthritis, Kenneth Calamia MD of the Mayo Clinic, who will offer an update on Behcet’s disease, Alan Baer of Johns Hopkins University, who will discuss Sjogren’s syndrome, and Maria Suzrez-Almazor MD PhD of the University of Texas MD Anderson Cancer Center, who will introduce rheumatic complications of checkpoint inhibitors.



Registration
Early Bird Registration (On or Before August 7, 2018)
$100.00 Physicians
$50.00 Other Health Care Professionals

Registration Fee (After August 7)
$125 Physicians
$75 Other Health Care Professionals

No registration refunds will be made after August 17, 2018
Written notification of cancellation must be postmarked on/or before August 24, 2018. 

Cancellation fee is $25



Accreditation

The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Conflict Resolution Statement
The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.

Nondiscrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices or procedures. This includes, but is not limited to: admissions, employment, financial aid and educational services. Inquiries regarding non-discrimination policies may be directed to: Bobby J. Mason, Institutional Equity Officer, (405) 325-3546, bjm@ou.edu, or visit www.ou.edu/eoo.

Accommodation Statement:

Accommodations on the basis of disability are available by contacting Nicole Lung at (405) 271-2330 or nicole-lung@ouhsc.edu as soon as possible.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure 
It is the policy of the University of Oklahoma, College of Medicine that the faculty and presenters disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).  

Planning Committee
Matlock Jeffries, MD, Course Director
Mary Beth Humphrey, MD
Priya Prakash, MD
Quratul Raja, MD, Fellow
Nicole Lung, Course Contact